You are here

Cesium-131 Sources for Brachytherapy

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 CA62664-1,
Agency Tracking Number: 24833
Amount: $80,719.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 1994
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
7643-B Fullerton Road
Springfield, VA 22153
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Krishnan Suthanthiran
 (703) 451-2378
Business Contact
Phone: () -
Research Institution

Low energy X and Gamma ray sources such as Cs-131 (9.7 Days T1/2, 30 keV) are extremelyuseful in cancer therapy with obvious advantages such as ease of shielding, useful range in tissue. SinceCs-131 is capable of forming insoluble metal complexes with metal salts such as AmmoniumMolybdophosphate, it is intended to exploit this property of Cesium in this study. The purpose of thepresent study is to explore the feasibility of commercially manufacturing radioactive sources of Cs-131technologically superior and better capable than existing ones, of providing uniform distribution ofradioactivity and desirable safety characteristics. We plan to accomplish this project in several steps:a. complex formation with a suitable metal as a substrate, from which Cesium does not dissociate, b.seed manufacture, consisting of central tungsten core coated with a suitable metal complex; filmmanufacture, consisting of suitable membrane coated with a suitable metal complex, c. evaluation ofradioactive source integrity against leakage using conventional procedures, and d. evaluation ofuniformity of dose distribution in the radioactive source and clinical potential by dose and dose ratemeasurements.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government